Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idex (IEX) EBIT (2016 - 2025)

Idex (IEX) has disclosed EBIT for 17 consecutive years, with $183.6 million as the latest value for Q4 2025.

  • On a quarterly basis, EBIT rose 11.07% to $183.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $699.3 million, a 3.26% increase, with the full-year FY2025 number at $699.3 million, up 3.26% from a year prior.
  • EBIT was $183.6 million for Q4 2025 at Idex, down from $185.8 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $202.2 million in Q3 2022 to a low of $142.0 million in Q1 2025.
  • A 5-year average of $174.9 million and a median of $177.3 million in 2022 define the central range for EBIT.
  • Peak YoY movement for EBIT: skyrocketed 43.14% in 2021, then decreased 16.17% in 2024.
  • Idex's EBIT stood at $162.0 million in 2021, then grew by 8.02% to $175.0 million in 2022, then fell by 8.29% to $160.5 million in 2023, then rose by 2.99% to $165.3 million in 2024, then rose by 11.07% to $183.6 million in 2025.
  • Per Business Quant, the three most recent readings for IEX's EBIT are $183.6 million (Q4 2025), $185.8 million (Q3 2025), and $187.9 million (Q2 2025).